163 related articles for article (PubMed ID: 19528078)
21. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
22. hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations.
Isenmann S; Cakouros D; Zannettino A; Shi S; Gronthos S
J Bone Miner Res; 2007 Jun; 22(6):897-906. PubMed ID: 17352650
[TBL] [Abstract][Full Text] [Related]
23. p53-dependent down-regulation of telomerase is mediated by p21waf1.
Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter.
Lee D; Kim HZ; Jeong KW; Shim YS; Horikawa I; Barrett JC; Choe J
J Biol Chem; 2002 Aug; 277(31):27748-56. PubMed ID: 12019268
[TBL] [Abstract][Full Text] [Related]
25. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
Chang JT; Yang HT; Wang TC; Cheng AJ
Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
[TBL] [Abstract][Full Text] [Related]
26. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
[TBL] [Abstract][Full Text] [Related]
27. The hTERT gene is embedded in a nuclease-resistant chromatin domain.
Wang S; Zhu J
J Biol Chem; 2004 Dec; 279(53):55401-10. PubMed ID: 15516693
[TBL] [Abstract][Full Text] [Related]
28. [Cloning of human telomerase reverse transcriptase promoter for targeted cancer therapy].
Li F; Tan XH; Peng XJ; Cai HB; Hu DR
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):207-11. PubMed ID: 15699008
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells.
Cong YS; Bacchetti S
J Biol Chem; 2000 Nov; 275(46):35665-8. PubMed ID: 10986277
[TBL] [Abstract][Full Text] [Related]
30. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
31. Repression of human telomerase reverse transcriptase using artificial zinc finger transcription factors.
Sohn JH; Yeh BI; Choi JW; Yoon J; Namkung J; Park KK; Kim HW
Mol Cancer Res; 2010 Feb; 8(2):246-53. PubMed ID: 20145034
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated suicide SCLC gene therapy using the increased activity of the hTERT promoter by the MMRE and SV40 enhancer.
Song JS
Biosci Biotechnol Biochem; 2005 Jan; 69(1):56-62. PubMed ID: 15665468
[TBL] [Abstract][Full Text] [Related]
33. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1.
Verma SC; Borah S; Robertson ES
J Virol; 2004 Oct; 78(19):10348-59. PubMed ID: 15367601
[TBL] [Abstract][Full Text] [Related]
34. Specific expression of Cre recombinase in hypertrophic cartilage under the control of a BAC-Col10a1 promoter.
Gebhard S; Hattori T; Bauer E; Schlund B; Bösl MR; de Crombrugghe B; von der Mark K
Matrix Biol; 2008 Oct; 27(8):693-9. PubMed ID: 18692570
[TBL] [Abstract][Full Text] [Related]
35. Targeted transgene insertion into the CHO cell genome using Cre recombinase-incorporating integrase-defective retroviral vectors.
Kawabe Y; Shimomura T; Huang S; Imanishi S; Ito A; Kamihira M
Biotechnol Bioeng; 2016 Jul; 113(7):1600-10. PubMed ID: 26724679
[TBL] [Abstract][Full Text] [Related]
36. Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element.
Horikawa I; Chiang YJ; Patterson T; Feigenbaum L; Leem SH; Michishita E; Larionov V; Hodes RJ; Barrett JC
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18437-42. PubMed ID: 16344462
[TBL] [Abstract][Full Text] [Related]
37. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene.
Horikawa I; Cable PL; Afshari C; Barrett JC
Cancer Res; 1999 Feb; 59(4):826-30. PubMed ID: 10029071
[TBL] [Abstract][Full Text] [Related]
38. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.
Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO
Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922
[TBL] [Abstract][Full Text] [Related]
39. C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter.
Racek T; Mise N; Li Z; Stoll A; Pützer BM
J Biol Chem; 2005 Dec; 280(49):40402-5. PubMed ID: 16234237
[TBL] [Abstract][Full Text] [Related]
40. Mapping lineage using BAC-Cre reporter lines.
Xu Q; Anderson SA
Curr Protoc Neurosci; 2010 Jan; Chapter 1():Unit 1.19. PubMed ID: 20066654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
